I am 56, male. How can I manage my poorly controlled T2D?

Question

Hello doctor,

I am a 56-year-old man diagnosed with type 2 diabetes mellitus 10 years ago, and my blood sugar control has become increasingly unstable over the past year. Despite taking Metformin 1000 mg twice daily and Glimepiride 2 mg, my recent HbA1c is 9.2%, and my fasting blood sugar averages around 180 mg/dL. I have also gained about 17 pounds in the past year, and my BMI is 32, indicating obesity.

I feel constantly tired, thirsty, and wake up several times at night to urinate. My cholesterol is 245 mg/dL, and my triglycerides are 310 mg/dL, so my doctor recently added Atorvastatin 20 mg. I have started to notice tingling and burning in my feet, which worries me about developing diabetic neuropathy. My creatinine is 1.3 mg/dL, and my urine microalbumin is mildly elevated, suggesting early kidney involvement.

I try to walk daily, but my job requires long hours sitting at a desk, and I often skip meals or eat takeout. My doctor suggested adding an SGLT2 inhibitor or GLP-1 receptor agonist for better control and heart protection, but I am unsure which is safer and more effective. Are there newer combination therapies or lifestyle programs that can help me lower my sugars, protect my organs, and possibly reduce my medication load?

Please advise.

Thank you.

Answer 1

Hello,

Welcome to icliniq.com.

I am very sorry you are going through this.

You are describing poorly controlled type 2 diabetes with early complications, including neuropathy (burning feet) and mild kidney involvement. Your HbA1c (glycated hemoglobin) of 9.2% means your average sugar is around 210 mg/dL, well above target (more than 7 %). This level increases the risk of heart, nerve, and kidney problems. Weight gain and tiredness also suggest that insulin resistance is worsening.

Since Metformin and Glimepiride are no longer enough, your doctor’s suggestion is right, adding one of the newer classes can improve control and protect your heart and kidneys. Such as:

SGLT2 (sodium-glucose cotransporter-2) inhibitors (Empagliflozin, Dapagliflozin): These help lower blood sugar by excreting glucose through urine, promote mild weight loss, and lower blood pressure. They also protect the kidneys and reduce the risk of heart failure. But, it can cause side effects like genital fungal infections and dehydration risk if not well hydrated.
GLP-1 (glucagon-like peptide-1) receptor agonists (Liraglutide, Semaglutide, Dulaglutide): These reduce sugar and promote significant weight loss, reduce appetite, and improve heart outcomes. These can be injectable (weekly or daily) or oral (Semaglutide tablet). But it can cause side effects like nausea or mild stomach upset early on.

Often, doctors combine Metformin, an SGLT2 inhibitor, and a GLP-1 agonist, which gives the best sugar control with organ protection and weight loss, sometimes allowing later dose reduction of Glimepiride or even stopping it.

Medication works best when paired with consistent habits such as:

Diet: Small, regular meals; high protein and fiber; avoid sugary drinks, white rice, and fried food.
Exercise: 30 to 40 min brisk walk daily plus light strength training two to three times weekly.
Sleep and stress: Poor sleep raises insulin resistance; practice mindfulness or yoga.
Foot care: Inspect feet daily, wear soft shoes, and control sugar to prevent neuropathy progression.

Lastly, keep checking your fasting and post-meal sugar levels regularly, recheck HbA1c every three months, and have annual kidney, eye, and nerve evaluations.

For you, adding an SGLT2 inhibitor (for kidney and heart protection) and possibly a GLP-1 agonist (for weight loss and strong sugar control) is the most effective and modern combination. Both are safe under medical supervision and may even let you reduce other drugs over time. Combine this with a structured diet, exercise, and stress control, and your sugars, weight, and long-term risks can all improve significantly.

I hope this answers your query.

Please follow up if you have more questions.

Thank you.